002166 萊茵生物
按盤價 
6.800 -0.350 (-4.895%)
6.800 -0.350 (-4.895%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.340 | 4.558 | 5.212 | 2.663 | 7.246 |
| 總資產報酬率 ROA (%) | 0.809 | 2.752 | 3.380 | 1.817 | 4.634 |
| 投入資產回報率 ROIC (%) | 0.961 | 3.330 | 4.033 | 2.143 | 5.607 | 邊際利潤分析 |
| 銷售毛利率 (%) | 23.717 | 25.751 | 29.325 | 24.415 | 30.799 |
| 營業利潤率 (%) | 11.550 | 10.029 | 12.046 | 7.920 | 18.111 |
| 息稅前利潤/營業總收入 (%) | 14.607 | 11.965 | 13.477 | 9.424 | 17.576 |
| 淨利潤/營業總收入 (%) | 9.542 | 7.480 | 9.435 | 6.583 | 13.442 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.605 | 92.142 | 103.940 | 75.378 | 94.044 |
| 價值變動淨收益/利潤總額(%) | -0.465 | 4.408 | 4.428 | 43.120 | 16.608 |
| 營業外收支淨額/利潤總額(%) | -0.030 | -2.126 | -2.690 | -1.683 | -6.442 | 償債能力分析 |
| 流動比率 (X) | 1.765 | 1.597 | 1.704 | 2.032 | 2.513 |
| 速動比率 (X) | 1.002 | 0.893 | 0.925 | 1.222 | 1.635 |
| 資產負債率 (%) | 36.172 | 39.800 | 36.220 | 30.723 | 30.126 |
| 帶息債務/全部投入資本 (%) | 23.877 | 24.181 | 20.775 | 15.726 | 13.996 |
| 股東權益/帶息債務 (%) | 301.396 | 295.177 | 360.235 | 509.482 | 577.684 |
| 股東權益/負債合計 (%) | 171.941 | 147.351 | 171.853 | 220.366 | 228.331 |
| 利息保障倍數 (X) | 4.772 | 5.578 | 7.718 | 5.763 | 31.330 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 238.654 | 198.195 | 148.472 | 106.842 | 76.234 |
| 存貨周轉天數 (天) | 331.956 | 299.095 | 312.736 | 302.341 | 298.241 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 23/06/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
